TAO Synergies Inc.
TAOX- Exchange
- Nasdaq
- Industry
- Finance Services
- SEC CIK
- 0001571934
No open-market purchases or sales by TAO Synergies Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.66M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by TAO Synergies Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for TAO Synergies Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Weinstein Robert | Chief Financial Officer | 16,574 | May 19, 2026 | 2 |
| Silverman Joshua | Executive Chairman | 86,681 | May 19, 2026 | 2 |
| Singer William S. | Director | 19,566 | May 19, 2026 | 3 |
| Bernstein Bruce | Director | 30,897 | May 19, 2026 | 3 |
| Ephron Robert | Director | 4,500 | May 19, 2026 | 3 |
| Schechter Jonathan | Director | 14,035 | Oct 17, 2025 | 1 |
| Tuchman Alan J | Chief Medical Officer | 3,909 | Jul 2, 2025 | 0 |
| Alkon Daniel L. | President and CSO | 35,546 | Dec 20, 2022 | 0 |
| Perry George | Director | 40,000 | Jul 15, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Singer William S.Director | SSaleCommon Stock, par value $0.0001 per share | −27.0K | $1.17 | −$31.6K | −45.0%33.0K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Weinstein RobertChief Financial Officer | SSaleCommon Stock, par value $0.0001 per share | −27.0K | $1.17 | −$31.6K | −44.9%33.2K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Silverman JoshuaDirector | SSaleCommon Stock, par value $0.0001 per share | −19.0K | $1.17 | −$22.2K | −33.2%38.2K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Schechter JonathanDirector | SSaleCommon Stock, par value $0.0001 per share | −20.3K | $1.17 | −$23.7K | −41.5%28.5K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Alkon Daniel L.President and CSO | SSaleCommon Stock, par value $0.0001 per share | −19.7K | $1.17 | −$23.0K | −35.6%35.5K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Bernstein BruceDirector | SSaleCommon Stock, par value $0.0001 per share | −22.5K | $1.17 | −$26.3K | −44.9%27.6K after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Tuchman Alan JChief Executive Officer | SSaleCommon Stock, par value $0.0001 per share | −27.0K | $1.17 | −$31.6K | −45.0%33.0K after |